Main Business / Finance News Today
Share buybacks in Spar Nord Bank transactions in week 03
OPENING OF 2.25 PER CENT BULLET LOAN 2033
Municipality Finance issues EUR 10 million notes under its MTN programme
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
Complete Genomics to Announce New Product Launches at AGBT General Meeting
Former Ecolab University building in St. Paul sold to Inland Real Estate Group
2023-01-24 19:10:00

Bioxytran Interview at the Emerging Growth Conference

Logo Benzinga
Benzinga
By Globe Newswire

- Wednesday, January 25, 2023 10:50 am 11:20am EST

- Discussion of the Biotech Showcase Conference

BOSTON, MASSACHUSETTS, Jan. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. BIXT (the "Company"), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases announced that Bioxtran CMO Michael Sheikh will be discussing his attendance at the Biotech Showcase on the Emerging Growth Conference on January 25, 2023 at 10:50am EST. Investors are encouraged to preregister to ensure you are able to attend the conference and receive any updates that are released.

Event: Emerging Growth Conference

Date: January 25, 2023

Registration: https://goto.webcasts.com/starthere.jsp?ei=1575092&tp_key=9111d280ed&sti=bixt

Continue read on benzinga.com

Related Posts
Logo PR Newswire
HealthPress Release2023-01-24 12:00:00
Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics,...
Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide...
Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
2022 Novo Holdings Seed Investments team Review/Business Update
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...
Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
First Wave BioPharma to Present at Sequire Biotechnology Conference
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (First Wave BioPharma or the Company), a clinical-stage...
Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:21:00
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Company cofounder to discuss use of artificial intelligence and machine learning applications for precision medicine in neurology BOSTON, Jan. 24, 2023...
Logo GlobeNewswire
SciencePress Release2023-01-24 09:00:00
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab...
Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:36:00
FDA Agrees to Expanded Access Program for the BioVentrix Revivent TC System for the Treatment of Ischem
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix, Inc., a privately...
Logo PR Newswire
Business / FinancePress Release2023-01-23 19:46:00
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 25, 2023
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at...
Logo GlobeNewswire
SciencePress Release2023-01-24 06:30:00
Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023
Press Release Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023 January 24, 2023 release at 7:30 am CET Sophia...
Logo PR Newswire
HealthPress Release2023-01-24 12:36:00
FDA Agrees to Expanded Access Program for the BioVentrix® Revivent TC® System for the Treatment of Ischemic Heart...
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix ®, Inc., a...
Logo GlobeNewswire
SciencePress Release2023-01-23 21:05:00
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
SEATTLE, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology...
Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
Cerevance to Participate at the SVB Global Biopharma Conference
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...
Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:45:00
ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR to Treat Aggressive B-cell Lymphoma
Phase 1/2 clinical trial expected to launch in early 2023 and will evaluate safety and preliminary impact on disease activity of IMPT-314 WEST HILLS, Calif.,...
Logo PR Newswire
Business / FinancePress Release2023-01-24 12:30:00
Complete Genomics to Announce New Product Launches at AGBT General Meeting
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"),...
Logo EIN Presswire
HealthPress Release2023-01-24 14:43:13
Next-Generation Biomanufacturing Market : A Study of the Industry's Key Players and Their Strategies
Emergen Research Logo Increase in the number of biopharmaceutical companies across the nations driving the growth of next-generation biomanufacturing in...
Logo The Business Journals
Technology2023-01-23 19:47:07
Genetesis adds 3 to executive team as FDA 'de novo' approval looms
Genetesis has added three new executives to its team as it nears a key FDA approval.
Logo GlobeNewswire
HealthPress Release2023-01-24 13:30:00
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and...
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the Company or Nexalin) (Nasdaq: NXL; NXLIW), today announced the appointment of Michael...
Logo GlobeNewswire
EconomyPress Release2023-01-24 15:00:00
Biohacking Market Size to Hit USD 63 Billion by 2028 at 19% CAGR Report by Market Research Future (MRFR)
Biohacking Market Trends and Insights Type (Inside, Outside), Product (Smart Drugs, Sensors, Strains), Application (Synthetic, Genetic Engineering), End-user...
Logo GlobeNewswire
SciencePress Release2023-01-24 11:00:00
InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of...
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company,...
Logo Nasdaq
Business / FinanceBy Rtt News2023-01-24 10:06:59
Alvotech, Bioventure Announce Approval For Humira Biosimilar Simlandi In Saudi
(RTTNews) - Alvotech (ALVO) and Bioventure Tuesday announced manufacturing and distribution approval of AVT02, a biosimilar of Humira, by the Saudi Food and...